83 research outputs found

    A Novel Dynamic Measurement System for Evaluating the Braking Coordination of Articulated Vehicles

    Get PDF
    The braking coordination between tractor and semitrailer is vital to the safety of articulated vehicles. Traditional evaluation about braking coordination is based on the pressure measurement along air braking pipeline, which needs to change original braking structure to install gauges and cannot directly reflect the final braking coordination of different wheels. To overcome these limitations, this paper proposes a novel dynamic measurement system for evaluating the braking coordination of articulated vehicles. During the brake test, all wheel velocities of the whole articulated vehicle are synchronously obtained through a specially designed distributed acquisition platform. To effectively eliminate gross errors and noises in wheel angular velocity data, a 3-order autoregressive (AR) model and an improved-thresholding wavelet filtering algorithm are developed. Further, a novel direct evaluation method about braking coordination is proposed according to the differences in angular velocity dropping time of all wheels. Finally, the overall system is assessed through real field tests. The results validate the feasibility and effectiveness of the proposed system

    Scalable Scheduling for Industrial Time-Sensitive Networking: A Hyper-flow Graph Based Scheme

    Full text link
    Industrial Time-Sensitive Networking (TSN) provides deterministic mechanisms for real-time and reliable flow transmission. Increasing attention has been paid to efficient scheduling for time-sensitive flows with stringent requirements such as ultra-low latency and jitter. In TSN, the fine-grained traffic shaping protocol, cyclic queuing and forwarding (CQF), eliminates uncertain delay and frame loss by cyclic traffic forwarding and queuing. However, it inevitably causes high scheduling complexity. Moreover, complexity is quite sensitive to flow attributes and network scale. The problem stems in part from the lack of an attribute mining mechanism in existing frame-based scheduling. For time-critical industrial networks with large-scale complex flows, a so-called hyper-flow graph based scheduling scheme is proposed to improve the scheduling scalability in terms of schedulability, scheduling efficiency and latency & jitter. The hyper-flow graph is built by aggregating similar flow sets as hyper-flow nodes and designing a hierarchical scheduling framework. The flow attribute-sensitive scheduling information is embedded into the condensed maximal cliques, and reverse maps them precisely to congestion flow portions for re-scheduling. Its parallel scheduling reduces network scale induced complexity. Further, this scheme is designed in its entirety as a comprehensive scheduling algorithm GH^2. It improves the three criteria of scalability along a Pareto front. Extensive simulation studies demonstrate its superiority. Notably, GH^2 is verified its scheduling stability with a runtime of less than 100 ms for 1000 flows and near 1/430 of the SOTA FITS method for 2000 flows

    A Hybrid Intelligent Multisensor Positioning Methodology for Reliable Vehicle Navigation

    Get PDF
    With the rapid development of intelligent transportation systems worldwide, it becomes more important to realize accurate and reliable vehicle positioning in various environments whether GPS is available or not. This paper proposes a hybrid intelligent multisensor positioning methodology fusing the information from low-cost sensors including GPS, MEMS-based strapdown inertial navigation system (SINS) and electronic compass, and velocity constraint, which can achieve a significant performance improvement over the integration scheme only including GPS and MEMS-based SINS. First, the filter model of SINS aided by multiple sensors is presented in detail and then an improved Kalman filter with sequential measurement-update processing is developed to realize the filtering fusion. Further, a least square support vector machine- (LS SVM-) based intelligent module is designed and augmented with the improved KF to constitute the hybrid positioning system. In case of GPS outages, the LS SVM-based intelligent module trained recently is used to predict the position error to achieve more accurate positioning performance. Finally, the proposed hybrid positioning method is evaluated and compared with traditional methods through real field test data. The experimental results validate the feasibility and effectiveness of the proposed method

    Function of TRP channels in monocytes/macrophages

    Get PDF
    The transient receptor potential channel (TRP channel) family is a kind of non- specific cation channel widely distributed in various tissues and organs of the human body, including the respiratory system, cardiovascular system, immune system, etc. It has been reported that various TRP channels are expressed in mammalian macrophages. TRP channels may be involved in various signaling pathways in the development of various systemic diseases through changes in intracellular concentrations of cations such as calcium and magnesium. These TRP channels may also intermingle with macrophage activation signals to jointly regulate the occurrence and development of diseases. Here, we summarize recent findings on the expression and function of TRP channels in macrophages and discuss their role as modulators of macrophage activation and function. As research on TRP channels in health and disease progresses, it is anticipated that positive or negative modulators of TRP channels for treating specific diseases may be promising therapeutic options for the prevention and/or treatment of disease

    Genomic Analyses Reveal Mutational Signatures and Frequently Altered Genes in Esophageal Squamous Cell Carcinoma

    Get PDF
    Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers worldwide and the fourth most lethal cancer in China. However, although genomic studies have identified some mutations associated with ESCC, we know little of the mutational processes responsible. To identify genome-wide mutational signatures, we performed either whole-genome sequencing (WGS) or whole-exome sequencing (WES) on 104 ESCC individuals and combined our data with those of 88 previously reported samples. An APOBEC-mediated mutational signature in 47% of 192 tumors suggests that APOBEC-catalyzed deamination provides a source of DNA damage in ESCC. Moreover, PIK3CA hotspot mutations (c.1624G>A [p.Glu542Lys] and c.1633G>A [p.Glu545Lys]) were enriched in APOBEC-signature tumors, and no smoking-associated signature was observed in ESCC. In the samples analyzed by WGS, we identified focal (<100 kb) amplifications of CBX4 and CBX8. In our combined cohort, we identified frequent inactivating mutations in AJUBA, ZNF750, and PTCH1 and the chromatin-remodeling genes CREBBP and BAP1, in addition to known mutations. Functional analyses suggest roles for several genes (CBX4, CBX8, AJUBA, and ZNF750) in ESCC. Notably, high activity of hedgehog signaling and the PI3K pathway in approximately 60% of 104 ESCC tumors indicates that therapies targeting these pathways might be particularly promising strategies for ESCC. Collectively, our data provide comprehensive insights into the mutational signatures of ESCC and identify markers for early diagnosis and potential therapeutic targets

    Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease

    Get PDF
    BACKGROUND: Patients with atherosclerotic vascular disease remain at high risk for cardiovascular events despite effective statin-based treatment of low-density lipoprotein (LDL) cholesterol levels. The inhibition of cholesteryl ester transfer protein (CETP) by anacetrapib reduces LDL cholesterol levels and increases high-density lipoprotein (HDL) cholesterol levels. However, trials of other CETP inhibitors have shown neutral or adverse effects on cardiovascular outcomes. METHODS: We conducted a randomized, double-blind, placebo-controlled trial involving 30,449 adults with atherosclerotic vascular disease who were receiving intensive atorvastatin therapy and who had a mean LDL cholesterol level of 61 mg per deciliter (1.58 mmol per liter), a mean non-HDL cholesterol level of 92 mg per deciliter (2.38 mmol per liter), and a mean HDL cholesterol level of 40 mg per deciliter (1.03 mmol per liter). The patients were assigned to receive either 100 mg of anacetrapib once daily (15,225 patients) or matching placebo (15,224 patients). The primary outcome was the first major coronary event, a composite of coronary death, myocardial infarction, or coronary revascularization. RESULTS: During the median follow-up period of 4.1 years, the primary outcome occurred in significantly fewer patients in the anacetrapib group than in the placebo group (1640 of 15,225 patients [10.8%] vs. 1803 of 15,224 patients [11.8%]; rate ratio, 0.91; 95% confidence interval, 0.85 to 0.97; P=0.004). The relative difference in risk was similar across multiple prespecified subgroups. At the trial midpoint, the mean level of HDL cholesterol was higher by 43 mg per deciliter (1.12 mmol per liter) in the anacetrapib group than in the placebo group (a relative difference of 104%), and the mean level of non-HDL cholesterol was lower by 17 mg per deciliter (0.44 mmol per liter), a relative difference of -18%. There were no significant between-group differences in the risk of death, cancer, or other serious adverse events. CONCLUSIONS: Among patients with atherosclerotic vascular disease who were receiving intensive statin therapy, the use of anacetrapib resulted in a lower incidence of major coronary events than the use of placebo. (Funded by Merck and others; Current Controlled Trials number, ISRCTN48678192 ; ClinicalTrials.gov number, NCT01252953 ; and EudraCT number, 2010-023467-18 .)
    corecore